Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

  • Patricia Spilman,
  • Natalia Podlutskaya,
  • Matthew J. Hart,
  • Jayanta Debnath,
  • Olivia Gorostiza,
  • Dale Bredesen,
  • Arlan Richardson,
  • Randy Strong,
  • Veronica Galvan
  • Article
  • Metrics
  • Comments
  • Media Coverage

The affiliation for the first author was incorrect. Patricia Spilman is not affiliated with #8 but with #1 Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America, and #2 The Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.

Citation: Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, et al. (2011) Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease. PLoS ONE 6(11): 10.1371/annotation/05c1b976-7eab-4154-808d-0526e604b8eb. https://doi.org/10.1371/annotation/05c1b976-7eab-4154-808d-0526e604b8eb

Published: November 18, 2011

Copyright: © 2011 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Competing interests: No competing interests declared.